What is Atossa Therapeutics, Inc. Common Stock's Market Cap?

Atossa Therapeutics, Inc. Common Stock's Market Cap is $25.4M, based on as-reported figures from SEC (XBRL) filings.

What is Atossa Therapeutics, Inc. Common Stock's Enterprise Value?

Atossa Therapeutics, Inc. Common Stock's Enterprise Value is -$646.8K, based on as-reported figures from SEC (XBRL) filings.

What is Atossa Therapeutics, Inc. Common Stock's EV / EBITDA?

Atossa Therapeutics, Inc. Common Stock's EV / EBITDA is 0.0×, based on as-reported figures from SEC (XBRL) filings.

What is Atossa Therapeutics, Inc. Common Stock's Net Income (TTM)?

Atossa Therapeutics, Inc. Common Stock's Net Income (TTM) is -$37.7M, based on as-reported figures from SEC (XBRL) filings.

What is Atossa Therapeutics, Inc. Common Stock's EBITDA?

Atossa Therapeutics, Inc. Common Stock's EBITDA is -$39.2M, based on as-reported figures from SEC (XBRL) filings.

What is Atossa Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Atossa Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.78, based on as-reported figures from SEC (XBRL) filings.

What is Atossa Therapeutics, Inc. Common Stock's Net Debt?

Atossa Therapeutics, Inc. Common Stock's Net Debt is -$26.1M, based on as-reported figures from SEC (XBRL) filings.

Atossa Therapeutics, Inc. Common Stock (ATOS) Financial Statements

Atossa Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG002NCD954

XNAS · usd

2.55▲ 0.03 (1.19%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close2.52

Day's Range2.50 – 2.60

52-Week Range0.53 – 7.59

Volume28.0K

Avg Volume55.8K

Share Statistics

Shares Outstanding

Employees14

ExchangeXNAS

Listed2012-11-08

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Atossa Therapeutics, Inc. Common Stock (ATOS)

What is Atossa Therapeutics, Inc. Common Stock's Market Cap?: Atossa Therapeutics, Inc. Common Stock's Market Cap is $25.4M, based on as-reported figures from SEC (XBRL) filings.
What is Atossa Therapeutics, Inc. Common Stock's Enterprise Value?: Atossa Therapeutics, Inc. Common Stock's Enterprise Value is -$646.8K, based on as-reported figures from SEC (XBRL) filings.
What is Atossa Therapeutics, Inc. Common Stock's EV / EBITDA?: Atossa Therapeutics, Inc. Common Stock's EV / EBITDA is 0.0×, based on as-reported figures from SEC (XBRL) filings.
What is Atossa Therapeutics, Inc. Common Stock's Net Income (TTM)?: Atossa Therapeutics, Inc. Common Stock's Net Income (TTM) is -$37.7M, based on as-reported figures from SEC (XBRL) filings.
What is Atossa Therapeutics, Inc. Common Stock's EBITDA?: Atossa Therapeutics, Inc. Common Stock's EBITDA is -$39.2M, based on as-reported figures from SEC (XBRL) filings.
What is Atossa Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Atossa Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.78, based on as-reported figures from SEC (XBRL) filings.
What is Atossa Therapeutics, Inc. Common Stock's Net Debt?: Atossa Therapeutics, Inc. Common Stock's Net Debt is -$26.1M, based on as-reported figures from SEC (XBRL) filings.